Predicting liver failure after surgery in patients with chronic liver disease
Official title: Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease
Run by University Hospital, Bonn · NCT04578301 · Data updated 2026-11-12
This study is trying to find out what causes liver failure after surgery in people with chronic liver disease to help doctors better predict risks for their patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University Hospital, Bonn Academic / other |
| Locations | 1 site (Bonn) |
| Status | Recruiting |
| Started | September 22, 2020 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | May 18, 2022 |
| Trial ID | NCT04578301 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients with or without liver cirrhosis who require surgical intervention.
✕Probably not a fit
Patients undergoing surgery for palliative cancer therapy or those with acute liver failure without underlying cirrhosis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify the precipitants and predictors of Acute-on-Chronic Liver Failure (ACLF) following surgical interventions in patients with chronic liver disease. By investigating clinical markers and molecular mechanisms associated with ACLF, the study seeks to develop a risk stratification tool for elective surgeries in cirrhotic patients. The research will involve prospective data collection from patients undergoing surgery, with a focus on understanding the underlying causes of ACLF and its relationship with surgical procedures.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and management strategies for patients with chronic liver disease undergoing surgery.
How similar studies have gone: While the study addresses a relatively novel area, previous research has indicated the importance of identifying risk factors for ACLF, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female adult (≥18 years) patient * With or without liver cirrhosis (diagnosed either histologically or by a combination of clinical, laboratory and radiological signs) * Or Non-cirrhotic portal hypertension * Non-pregnant, non-lactating females * Ability to understand the patient information and to personally sign and date the informed consent to participate in the study * The patient is co-operative and available for the entire study * Provided written informed consent * Indication for surgical intervention Exclusion Criteria: * Pregnant or lactating females * Patients undergoing surgery as form of palliative cancer therapy * Presence or history of severe extra-hepatic diseases * HIV-positive patients * Previous liver or other transplantation * Patients with acute or subacute liver failure without underlying cirrhosis * Patients who decline to participate * Physician´s denial (e.g. the investigator considers that the patient will not follow the protocol scheduled)
Where it's running
-
University Hospital Bonn
Bonn, Germany Recruiting
Study contacts
- Principal investigator: Michael Praktiknjo, MD — University Hospital, Bonn
- Study coordinator: Michael Praktiknjo, MD
- Email: michael.praktiknjo@ukbonn.de
- Phone: +4922828716375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for patients undergoing TIPS implantation for portal hypertension
This study is collecting information from patients with serious portal hypertension who are getting a TIPS procedure to see how well it works and what complications might happen afterward.
-
Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS
A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.
-
Austrian PBC Registry
This registry follows adults with primary biliary cholangitis in Austrian centers to see how the disease develops over time and how biomarkers relate to complications and symptoms.
-
Blood clotting and portal vein changes during TIPS placement in cirrhosis
This project will see how blood clotting in the body and in the portal vein changes in adults with cirrhosis who are having a TIPS placed.
-
Comparing HVPG and endoscopic ultrasound portal pressure measurements
This study will test whether an endoscopic ultrasound method (EUS-PPG) gives the same portal pressure readings as the standard hepatic venous pressure gradient (HVPG) in adults who need portal pressure measurement.
-
Handgrip strength and portal vein blood flow in people with liver cirrhosis
This trial will test whether squeezing a handgrip changes portal vein and left gastric vein pressures and blood flow in adults with liver cirrhosis to see if muscle strength affects variceal hemodynamics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.